News | April 10, 2023
Thermo Fisher Scientific expands its capabilities in France
Bourgoin early development hub broadens offerings for oral solid dose formulations
Bourgoin early development hub broadens offerings for oral solid dose formulations
The observations are procedural in nature
Based on this inspection and the USFDA VAI classification, this facility is in compliance with regard to current good manufacturing practices (cGMP)
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region
Cipla has received 8 inspectional observations in Form 483
It will help upgrade the infrastructure and technologies of the country's biopharmaceuticals and in-vitro diagnostic industry
The company is pleased to report positive performances from all divisions this quarter. Growth in our research divisions, Discovery Services and the Dedicated Centres was solid
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
The company remains committed to maintain the highest standards of compliance and will work closely with the agency to comprehensively address all the observations
Subscribe To Our Newsletter & Stay Updated
